Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Italian with Elisa (PDF)
Volume 1 | Volume 2

Free Abstracts

  Hepatitis

  Free Subscription


02.02.2015

3 Arch Virol
1 Eur J Gastroenterol Hepatol
2 Hepatology
3 J Clin Microbiol
1 J Hepatol
1 J Med Virol
10 J Viral Hepat
1 J Virol
1 Lancet Glob Health
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. SHAWKY H, Maghraby AS, Solliman ME, El-Mokadem MT, et al
    Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available

  2. HUANG D, Hennequi M, Elvachev A, Menguy T, et al
    The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available

  3. DONG Y, Qiu C, Xia X, Wang J, et al
    Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  4. RODRIGUES-PINTO E, Cardoso H, Coelho R, Andrade P, et al
    Higher aspartate aminotransferase platelet ratio index predicts early significant liver-related events in hepatitis C genotype 1 chronic liver disease.
    Eur J Gastroenterol Hepatol. 2015;27:361-2.
    PubMed     Text format    


    Hepatology

  5. JANG JW, Choi JY, Kim YS, Woo HY, et al
    Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis.
    Hepatology. 2015 Jan 27. doi: 10.1002/hep.27723.
    PubMed     Text format     Abstract available

  6. YAN H, Yang Y, Zhang L, Tang G, et al
    Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Hepatology. 2015 Jan 27. doi: 10.1002/hep.27722.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  7. FREEYA NJAI H, Shimakawa Y, Sanneh B, Ferguson L, et al
    Validation of rapid point-of-care (POC) tests for the detection of hepatitis B surface antigen (HBsAg) in field and laboratory settings in The Gambia, West Africa.
    J Clin Microbiol. 2015 Jan 28. pii: JCM.02980.
    PubMed     Text format     Abstract available

  8. SILVA-PINTO A, Andrade J, Araujo F, Santos L, et al
    Reactivation of a Hepatitis B without core antibody: a case report.
    J Clin Microbiol. 2015 Jan 28. pii: JCM.03546.
    PubMed     Text format     Abstract available

  9. VILLIERS MB, Cortay JC, Cortes S, Bloquel B, et al
    Protein/peptide arrays to detect anti-Delta genotype 1, 6, 8 specific antibodies among Hepatitis D Virus infected patients by surface plasmon resonance imaging.
    J Clin Microbiol. 2015 Jan 28. pii: JCM.03002.
    PubMed     Text format     Abstract available


    J Hepatol

  10. WOLFFRAM I, Petroff D, Batz O, Jedrysiak K, et al
    Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    J Hepatol. 2015 Jan 21. pii: S0168-8278(15)00017.
    PubMed     Text format     Abstract available


    J Med Virol

  11. DEVI SG, Kumar A, Kar P, Husain SA, et al
    Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy.
    J Med Virol. 2014;86:1366-76.
    PubMed     Text format     Abstract available


    J Viral Hepat

  12. LIU H, Zhang H, Wan G, Sang Y, et al
    Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure.
    J Viral Hepat. 2014;21:499-507.
    PubMed     Text format     Abstract available

  13. COLOMBATTO P, Brunetto MR, Maina AM, Romagnoli V, et al
    HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNalpha2a and Ribavirin: a randomized controlled trial.
    J Viral Hepat. 2014;21:458-65.
    PubMed     Text format     Abstract available

  14. MATSUURA K, Tanaka Y, Watanabe T, Fujiwara K, et al
    ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B type.
    J Viral Hepat. 2014;21:466-74.
    PubMed     Text format     Abstract available

  15. PAPATHEODORIDIS GV, Manolakopoulos S, Margariti A, Papageorgiou MV, et al
    The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.
    J Viral Hepat. 2014;21:517-24.
    PubMed     Text format     Abstract available

  16. LABARGA P, Fernandez-Montero JV, Barreiro P, Pinilla J, et al
    Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy.
    J Viral Hepat. 2014;21:475-9.
    PubMed     Text format     Abstract available

  17. STEFANESCU H, Procopet B, Platon Lupsor M
    Modified spleen stiffness measurement: a step forward, but still not the solution to all problems in the noninvasive assessment of cirrhotic patients.
    J Viral Hepat. 2014;21:e54.
    PubMed     Text format    

  18. TU T, Mason WS, Clouston AD, Shackel NA, et al
    Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.
    J Viral Hepat. 2015 Jan 26. doi: 10.1111/jvh.12380.
    PubMed     Text format     Abstract available

  19. SHI Y, Lan Y, Cao F, Teng Y, et al
    Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients.
    J Viral Hepat. 2014;21:e39-47.
    PubMed     Text format     Abstract available

  20. LAARIBI AB, Zidi I, Hannachi N, Ben Yahia H, et al
    Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitis.
    J Viral Hepat. 2015 Jan 26. doi: 10.1111/jvh.12395.
    PubMed     Text format     Abstract available

  21. ZHANG X, Jia J, Dong J, Yu F, et al
    HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy.
    J Viral Hepat. 2014;21:491-8.
    PubMed     Text format     Abstract available


    J Virol

  22. BENEDICTO I, Gondar V, Molina-Jimenez F, Garcia-Buey L, et al
    Clathrin mediates infectious hepatitis C virus particle egress.
    J Virol. 2015 Jan 28. pii: JVI.03620.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  23. KAMAL-YANNI M
    Hepatitis C drug affordability.
    Lancet Glob Health. 2015;3:e73-4.
    PubMed     Text format    


    PLoS One


  24. Correction: Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice.
    PLoS One. 2015;10:e0117635.
    PubMed     Text format     Abstract available

  25. ROUET F, Deleplancque L, Mboumba BB, Sica J, et al
    Usefulness of a Fourth Generation ELISA Assay for the Reliable Identification of HCV Infection in HIV-Positive Adults from Gabon (Central Africa).
    PLoS One. 2015;10:e0116975.
    PubMed     Text format     Abstract available

  26. MAES P, Harries AD, Van den Bergh R, Noor A, et al
    Can timely vector control interventions triggered by atypical environmental conditions prevent malaria epidemics? A case-study from wajir county, kenya.
    PLoS One. 2014;9:e92386.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: